LAURA MORRISON: Open Payments
NPI 1801655006 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$530 in 26 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $320 · 2025 $530
Food & beverage: $530
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 4 | $92 |
| Travere Therapeutics, Inc. | 4 | $78 |
| Otsuka America Pharmaceutical, Inc. | 4 | $76 |
| Mallinckrodt Hospital Products Inc. | 4 | $72 |
| Vifor Pharma, Inc. | 3 | $57 |
| Ascendis Pharma Endocrinology Inc | 2 | $55 |
| Apellis Pharmaceuticals, Inc. | 1 | $35 |
| Lilly USA, LLC | 2 | $32 |
| SCPHARMACEUTICALS INC. | 1 | $20 |
| Alexion Pharmaceuticals, Inc. | 1 | $14 |
Products named: TARPEYO, Veltassa, Yorvipath, JYNARQUE, ACTHAR, Empaveli, TERLIVAZ, JARDIANCE.
Industry payments across SC — which companies pay providers there.
